This article was originally published on the Biopôle website. Read the original article AI in healthcare: ‘Don’t expect too much too
How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: A case study in alpha-1 antitrypsin deficiency
Volv Global is proud to be helping to organise the upcoming PCMG AI Symposium on AI in Clinical Trials, shaping
Volv Global at WODC Europe 2025 – Where Technology Meets Human Volv Global sits at the crucial intersection between technology
Volv Global CEO and Founder Christopher Rudolf will speak on optimising rare disease clinical trials with Real World Data at
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Recently, I had powerful thought come to me on reading
